VIDAL Mobile

VIDAL Mobile

Vidal®
4.2
Medical
1,000,000+ Downloads

Click to download now, finish the installation quickly, and directly unlock the all-round experience

Screenshots

Screenshot
Screenshot
Screenshot
Screenshot
Screenshot
Screenshot
Screenshot
Screenshot
Screenshot
Screenshot

Why it is essential

Drug information for clinical reference

VIDAL Mobile is a medical reference app for healthcare professionals, medical students and others who need structured medicine information on a phone. Developed by Vidal®, it provides access to monographs for more than 11,000 medicines, along with information on around 4,000 parapharmacy products. The app is designed for quick checks of drug details rather than general health advice.

Search medicines and treatment guidance

Users can look up products by trade name, active substance or indication. The reference content covers practical prescribing information and can remain available offline, which is useful in hospitals, clinics or other locations with limited connectivity. VIDAL Mobile also includes VIDAL Recos, with 185 therapeutic strategies and 260 decision trees prepared with input from medical experts.

Check combinations and equivalents

  • Prescription analysis: simulate combinations of medicines and review potential interactions or adverse reactions, with findings grouped by severity.
  • International equivalents: search for corresponding medicines across countries when treating patients who travel or move between healthcare systems.
  • Learning tools: use flash cards to review medicine-related information and reinforce study.

Ratings and suitable users

With a rating of 4.17 out of 5 from 7,289 reviews and more than 1,000,000 installs, VIDAL Mobile has a substantial Android user base. Its dense, reference-focused layout is better suited to users who already understand medical terminology than to people looking for simplified consumer health content. As with any clinical reference, its information should support—not replace—professional judgement and current prescribing guidance.